Immunology and Microbiology
Microflora
100%
Microbiome
67%
Streptococcus pneumonia
30%
Upper Respiratory Tract
28%
Infectious Agent
22%
Human Respiratory Syncytial Virus
20%
Intestine Flora
17%
Respiratory Syncytial Virus Infection
16%
Dynamics
16%
Viral Disease
13%
Streptococcus
13%
Pneumococcus
13%
Serotype
12%
Gut Microbiome
12%
Virus
11%
Microorganism
11%
COVID-19
10%
Antibody Response
10%
Bifidobacterium
10%
Asthma
9%
Corynebacterium
9%
Lower Respiratory Tract
9%
Laboratory Test
9%
Enterococcus
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Airway
8%
Maturation
8%
Moraxella
7%
Escherichia coli
7%
Human Microbiome
7%
Pneumococcal Vaccine
6%
Gene Expression
6%
Infancy
6%
RNA Gene
6%
Palivizumab
6%
Staphylococcus Aureus
6%
Neisseria
5%
Haemophilus influenzae
5%
Resistome
5%
Influenza Vaccine
5%
Transcriptome
5%
Susceptible Population
5%
Mycoplasma pneumoniae
5%
Asthma Exacerbation
5%
Immunoglobulin G
5%
Common Variable Immunodeficiency
5%
Arm
5%
Influenza Virus
5%
Brain Development
5%
Gut-Brain Axis
5%
Medicine and Dentistry
Microbiome
27%
Respiratory Tract Infection
25%
Upper Respiratory Tract
17%
Streptococcus pneumonia
14%
Infection
13%
Diseases
11%
Pneumococcal Pneumonia
11%
COVID-19
10%
Pathophysiology
8%
Cohort Study
8%
Mixed Infection
7%
Nasopharynx
6%
Human Respiratory Syncytial Virus
5%
Neisseria lactamica
5%
Virus
5%
Cystic Fibrosis
5%
Gut Microbiota
5%
Randomized Controlled Trial
5%
Biological Marker
5%
Cesarean Section
5%
Respiratory Syncytial Virus Infection
5%
Artificial Respiration
5%
Environmental Factor
5%
Procalcitonin
5%
Hospital Mortality
5%
Tympanostomy Tube Otorrhea
5%
Rhinovirus
5%
Lifespan
5%
Bacterial Shedding
5%
Flu Like Syndrome
5%
Arm
5%
Influenza Vaccine
5%
Third Trimester Pregnancy
5%
Trimethylamine
5%
Cathelicidin
5%
Lung Lavage
5%
Respiratory Disease
5%
Real-Time Polymerase Chain Reaction
5%
